Detalhe da pesquisa
1.
Spatial predictors of immunotherapy response in triple-negative breast cancer.
Nature
; 621(7980): 868-876, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37674077
2.
Management of cutaneous adverse events caused by antineoplastic therapies: a single-center experience.
Support Care Cancer
; 32(3): 200, 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38421520
3.
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial.
Int J Gynecol Cancer
; 34(4): 550-558, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38129136
4.
Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer.
Gynecol Oncol
; 170: 300-308, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36758420
5.
Post-operative residual disease and number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma.
Int J Gynecol Cancer
; 33(8): 1270-1278, 2023 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37429642
6.
Ribociclib plus letrozole in male patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: subgroup analysis of the phase IIIb CompLEEment-1 trial.
Breast Cancer Res Treat
; 193(1): 95-103, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35212906
7.
Management of malignant cutaneous wounds in oncologic patients.
Support Care Cancer
; 30(9): 7615-7623, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35672478
8.
A Long-Term Extension Study of Bevacizumab in Patients With Solid Tumors.
Oncologist
; 26(12): e2254-e2264, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34498344
9.
Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population.
Breast Cancer Res Treat
; 189(3): 689-699, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34414532
10.
COVID-19 free oncologic surgical hub: The experience of reallocation of a gynecologic oncology unit during pandemic outbreak.
Gynecol Oncol
; 161(1): 89-96, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33223219
11.
Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel.
Support Care Cancer
; 28(5): 2435-2442, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32048043
12.
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience.
J Cell Physiol
; 234(6): 7708-7717, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30536609
13.
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial.
BMC Med
; 17(1): 207, 2019 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31747948
14.
DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients.
Pharmacogenomics J
; 19(6): 556-563, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30723313
15.
Neoadjuvant treatment with trastuzumab and pertuzumab plus palbociclib and fulvestrant in HER2-positive, ER-positive breast cancer (NA-PHER2): an exploratory, open-label, phase 2 study.
Lancet Oncol
; 19(2): 249-256, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29326029
16.
Efficacy and Safety of Pertuzumab and Trastuzumab Administered in a Single Infusion Bag, Followed by Vinorelbine: VELVET Cohort 2 Final Results.
Oncologist
; 22(10): 1160-1168, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28592618
17.
Correction to: Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population.
Breast Cancer Res Treat
; 191(1): 223-224, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34625861
18.
Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: a case report.
BMC Cancer
; 17(1): 722, 2017 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29115937
19.
Eribulin long-term response and rechallenge: report of two clinical cases.
Future Oncol
; 13(11s): 35-43, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28481188
20.
Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study.
Int J Gynecol Cancer
; 27(1): 50-58, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27749456